Back to search
federal
501(c)(3) required
HealthMechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R21 Clinical Trial Not Allowed)
National Institutes of Health
Funding amount
Varies
Deadline
Jan 7, 2027
Geography
National (all U.S.)
Analyzing this grant for you…
About this grant
Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R21 Clinical Trial Not Allowed)
Eligibility
See opportunity page for eligibility details.
Required documents
- SF-424
- Project narrative
- Budget
Eligible organization types
Nonprofit
Always verify grant requirements directly with the funder before applying.